Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder affecting millions of people worldwide. AD pathology is mainly caused due to the deposition of amyloid beta (Aβ) peptide and upsurge of oxidative stress, the two major factors responsible for AD occurrence and progression. The current treatment strategies available are merely effective and lack long-term benefits against this disease, which necessitates the need for the use of antioxidants for managing/preventing AD pathology. Ferulic acid (FA), a natural antioxidant found in various fruits (such as orange and grapefruit), vegetables (such as broccoli and tomato), coffee beans and barley used in beverages (such as coffee and beer), can be utilized as a natural source of antioxidants against AD. Several studies have pointed towards the protective effects of FA against AD in vitro as well as in vivo. The antioxidant defence system is known to be compromised in AD, whereas the use of FA has been shown to restore the activities of antioxidant enzymes like superoxide dismutase (SOD), catalase (CAT) and heme oxygenase-1 (HO-1). FA has also been shown to destabilize the preformed Aβ fibrils both in vitro and in vivo. Several studies have pointed towards the neuroprotective role of FA through modulating the expression of several key proteins such as p38, Hsp70, ERK1/2, foxo3a and Akt, thus playing a key role towards neuroprotection. In addition, FA is also reported to inhibit the inflammatory responses induced by lipopolysaccharides (LPS) in microglia and also shown to modulate the β-secretase activity and improved AD-like pathology in transgenic mice model study. Inhibition of acetylcholinesterase (AChE) activity and restoration of mitochondrial membrane potential by FA has also been reported. Taken together, it is advocated that the use of FA in routine diet may effectively lower the risk of developing AD and can play an important role in managing the disease. In this book chapter, we will try to document and summarize the structure and functional aspects of FA along with the known benefits of it as a neuroprotective agent against AD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alzheimer A (1907) Ueber eine eigenartige Erkrankung der Hirnrinde. Centralblatt fur Nervenheilkunde and Psychiatrie 30:177–179
Selkoe DJ (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81:741–766
Glenner GG, Wong CW (1984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885–890
Wood JG, Mirra SS, Pollock NL, Binder LI (1986) Neurofibrillary tangles of Alzheimer’s disease share antigenic determinants with the axonal microtubule-associated protein tau. Proc Natl Acad Sci 83:4040–4043
Brion J, Passareiro E, Nunez J, Flament-Durand J (1985) Mise en evidence immunologique de la protein Tau au niveau des lesions de degenerescence neurofibrillaire de la maladie D’ Alzheimer. Arch Biol 95:229–235
Haas C, Selkoe DJ (1993) Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta peptide. Cell 75:1039–1042
Aronis A, Melendez JA, Golan O, Shilo S, Dicter N, Tirosh O (2003) Potentiation of Fas-mediated apoptosis by attenuated production of mitochondria-derived reactive oxygen species. Cell Death Differ 10(3):335–344
Hroudova J, Singh N, Fisar Z (2014) Mitochondrial dysfunctions in neurodegenerative diseases: relevance to alzheimer’s disease. BioMed Res Int 2014:1–9
Wang X, Fujioka B, Su H, Zhu X (2008) Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer’s disease patients. Am J Pathol 173(2):470–482
Kann O, Kovacs R (2007) Mitochondria and neuronal activity. Am J Physiol Cell Physiol 292:C641–C657
Kaur N, Dhiman M, Perez-Polo JR, Mantha AK (2015a) Ginkgolide B revamps neuroprotective role of apurinic/apyrimidinic endonuclease 1 and mitochondrial oxidative phosphorylation against Aβ(25-35) induced neurotoxicity in human neuroblastoma cells. J Neurosci Res 93(6):938–947
Kaur N, Sarkar B, Mittal S, Dhiman M, Taglialatela G, Perez-Polo RJ, Mantha AK (2015b) Oxidative stress events and neuronal dysfunction in Alzheimer’s disease: focus on APE1/Ref-1-mediated survival strategies. In: Free radicals in human health and disease. Springer, Noida, pp 175–207
Butterfield DA, Castegna A, Lauderback CM, Drake J (2002) Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death. Neurobiol Aging 23(5):655–664
Dexter DT, Carter CJ, Wells FR, Javoy Agid F, Agid Y, Lees A, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease. J Neurochem 52(2):381–389
Bostantjopoulou S, Kyriazis G, Katsarou Z, Kiosseoglou G, Kazis A, Mentenopoulos G (1996) Superoxide dismutase activity in early and advanced Parkinson’s disease. Funct Neurol 12(2):63–68
Zemlan FP, Thienhaus OJ, Bosmann HB (1989) Superoxide dismutase activity in Alzheimer’s disease: possible mechanism for paired helical filament formation. Brain Res 476(1):160–162
Omar RA, Chyan YJ, Andorn AC, Poeggeler B, Robakis NK, Pappolla MA (1999) Increased expression but reduced activity of antioxidant enzymes in Alzheimer’s disease. J Alzheimer’s Dis 1(3):139–145
Cudkowicz ME, McKenna YD, Sapp PE, Chin W, Geller B, Hayden DL, Brown RH (1997) Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 41(2):210–221
Yoon EJ, Park HJ, Kim GY, Cho H, Choi J, Park H, Jang J, Rhim H, Kang S (2009) Intracellular amyloid beta interacts with SOD1 and impairs the enzymatic activity of SOD1: implications for the pathogenesis of amyotrophic lateral sclerosis. Exp Mol Med 41(9):611–617
Bjorkhem I, Cedazo-Minguez A, Leoni V, Meaney S (2009) Oxysterols and neurodegenerative diseases. Mol Asp Med 30:171–179
Reed TT (2011) Lipid peroxidation and neurodegenerative disease. Free Radic Biol Med 51:1302–1319
Cao Y, Zhang Y, Qi J, Liu R, Zhang H, He L (2015) Ferulic acid inhibits H2O2 induced oxidative stress and inflammation in rat vascular smooth muscle cells via inhibition of the NADPH oxidase and NF-κB pathway. Int Immunopharmacol 28:1018–1025
Gill I, Kaur S, Kaur N, Dhiman M, Mantha AK (2017) Phytochemical ginkgolide B attenuates amyloid-β1-42 induced oxidative damage and altered cellular responses in human neuroblastoma SH-SY5Y cells. J Alzheimer’s Dis 2017:1–16
Lillenes SM, Stoen M, Gomez-Munoz M, Torp R, Gunther C, Nilsson LNG, Tonjum T (2013) Transient OGG1, APE1, PARP1 and Polβ expression in an Alzheimer’s disease mouse model. Mech Ageing Dev 134:466–477
Kaur N, Sarkar B, Gill I, Kaur S, Mittal S, Dhiman M, Palada PK, Perez-Polo R, Mantha AK (2016) Indian herbs and their therapeutic potential against Alzheimer’s disease: what makes them special. In: Neuroprotective effects of phytochemicals in neurological disorders. Wiley-Blackwell Publisher, New Delhi
D’Archivio M, Filesi C, Di Benedetto R, Gargiulo R, Giovannini C, Masella R (2007) Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita 43:348–361
Rechner AR, Pannala AS, Rice-Evans CA (2001) Caffeic acid derivatives in artichoke extract are metabolised to phenolic acids in vivo. Free Radic Res 35:195–202
Abdul HM, Butterfield DA (2005) Protection against amyloid beta-peptide(1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer’s disease. Biochim Biophys Acta 1741:140–148
Lin W, Peng Y, Hou C (2015) Ferulic acid protects PC12 neurons against hypoxia by inhibiting the p-MAPKs and COX-2 pathways. Iran J Basic Med Sci 18:478–484
Mancuso C, Santangelo R (2013) Ferulic acid: pharmacological and toxicological aspects. Food Chem Toxicol 65:185–195
Zhao BL, Li XJ, He RG, Cheng SJ, Xin WJ (1989) Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys 14:175–185
Moosavi F, Hosseini R, Saso L, Firuzi O (2016) Modulation of neurotrophic signaling pathways by polyphenols. Drug Des Dev Ther 10:23–42
Sultana R, Ravagna A, Abdul HM, Calabrese V, Butterfield DA (2005) Ferulic acid ethyl ester protects neurons against amyloid β-peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J Neurochem 92:749–758
Fang L, Kraus B, Lehmann J, Heilmann J, Zhang Y, Decker M (2008) Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates. Bioorg Med Chem Lett 18:2905–2909
Pi R, Mao X, Chao X, Cheng Z, Liu M, Duan X, Ye M, Chen X, Mei Z, Liu P, Li W, Han Y (2012) Tacrine-6-ferulic acid, a novel multifunctional dimer, inhibits amyloid-β-mediated Alzheimer’s disease-associated pathogenesis in vitro and in vivo. PLoS One 7:1–8
Pan W, Hu K, Bai P, Yu L, Ma Q, Li T, Sang Z (2016) Design, synthesis and evaluation of novel ferulic acid-memoquin hybrids as potential multifunctional agents for the treatment of Alzheimer’s disease. Bioorg Med Chem Lett 26(10):2539–2543
Lee KH, Shin BH, Shin KJ, Kim DJ, Yu J (2005) A hybrid molecule that prohibits amyloid fibrils and alleviates neuronal toxicity induced by β-amyloid (1-42). Biochem Biophys Res Commun 328:816–823
Chen Z, Digiacomo M, Tu Y, Gu Q, Wang S, Yang X, Nesi G (2017) Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer’s disease. Eur J Med Chem 125:784–792
Graf E (1992) Antioxidant potential of ferulic acid. Free Radic Biol Med 13(4):435–448
Kanski J, Aksenova M, Stoyanova A, Butterfield DA (2002) Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J Nutr Biochem 13:273–281
Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat Rev Neurosci 5:S18–S25
Fridovich I (1999) Fundamental aspects of reactive oxygen species, or what’s the matter with oxygen? Ann N Y Acad Sci 893(1):13–18
Bayer TA, Schafer S, Breyhan H, Wirths O, Treiber C, Multhaup G (2006) A vicious circle: role of oxidative stress, intraneuronal Abeta and Cu in Alzheimer’ disease. Clin Neuropathol 25:163–171
Roy S, Metya SK, Sannigrahi S, Rahaman N, Ahmed F (2013) Treatment with ferulic acid to rats with streptozotocin-induced diabetes: effects on oxidative stress, pro-inflammatory cytokines, and apoptosis in the pancreatic β cell. Endocrine 44(2):369–379
Xu X, Xiao H, Zhao J, Zhao T (2012) Cardioprotective effect of sodium ferulate in diabetic rats. Int J Med Sci 9(4):291–300
Gerin F, Erman H, Erboga M, Sener U, Yilmaz A, Seyhan H, Gurel A (2016) The effects of ferulic acid against oxidative stress and inflammation in formaldehyde-induced hepatotoxicity. Inflammation 39(4):1377–1386
Villareal MO, Sasaki K, Margout D, Savry C, Almaksour Z, Larroque M, Isoda H (2016) Neuroprotective effect of Picholine virgin olive oil and its hydroxycinnamic acids component against b-amyloid-induced toxicity in SH-SY5Y neurotypic cells. Cytotechnology 3:1–12
Doss HM, Dey C, Sudandiradoss C, Rasool MK (2016) Targeting inflammatory mediators with ferulic acid, a dietary polyphenol, for the suppression of monosodium urate crystal induced inflammation in rats. Life Sci 148:201–210
Shen Y, Zhang H, Wang L, Qian H, Qi Y, Miao X, Qi X (2015) Protective effect of ferulic acid against 2, 2′-azobis (2-amidinopropane) dihydrochloride-induced oxidative stress in PC12 cells. Cell Mol Biol (Noisy-le-Grand, France) 62(1):109–116
Chong YH, Shin YJ, Lee EO, Kayed R, Glabe CG, Tenner AJ (2006) ERK1/2 activation mediates Aβ oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem 281(29):20315–20325
Picone P, Nuzzo D, Carlo MD (2013) Ferulic acid: a natural antioxidant against oxidative stress induced by oligomeric A-beta on sea urchin embryo. Biol Bull 224:18–28
Hussein AM, Abbas KM, Abulseoud OA, Elhussainy EMA (2017) Effects of ferulic acid on oxidative stress, heat shock protein 70, connexin 43 and monoamines in hippocampus of pentylenetetrazole-kindled rats. Can J Physiol Pharmacol, (ja) 95(6):732–742
Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Finch CE (2000) Inflammation and Alzheimer’s disease. Neurobiol Aging 21(3):383–421
Kim HS, Cho JY, Kim DH, Yan JJ, Le HK, Suh HW, Song DK (2004) Inhibitory effects of long-term administration of ferulic acid on microglial activation induced by intracerebroventricular injection of β-amyloid peptide (1—42) in mice. Biol Pharm Bull 27(1):120–121
Huang F, Deng HM, Zhu MM, Xiao F, Yang L, Zhang ZJ, Nie H (2011) Inhibitory effect of ferulic acid on inflammatory response in microglia induced by lipopolysaccharides. Zool Res 32(3):311–316
Mori T, Koyama N, Guillot-Sestier MV, Tan J, Town T (2013) Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic mice. Plos One 8:1–16
Yan JJ, Cho JY, Kim KL, Jung JS, Huh SO, Suh HW, Kim YH, Song DK (2001) Protection against β-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Parmacol 133:89–96
Huang H, Hong Q, Tan HL, Xiao CR, Gao Y (2016) Ferulic acid prevents LPS-induced up-regulation of PDE4B and stimulates the cAMP/CREB signaling pathway in PC12 cells. Acta Pharmacol Sin 37:1543–1554
Chaturvedi RK, Beal MF (2013) Mitochondrial diseases of the brain. Free Radic Biol Med 63:1–29
Yogeeta SK, Raghavendran HRB, Gnanapragasam A, Subhashini R, Devaki T (2006) Ferulic acid with ascorbic acid synergistically extenuates the mitochondrial dysfunction during β-adrenergic catecholamine induced cardiotoxicity in rats. Chem Biol Interact 163(1):160–169
Harrison SM, Harper AJ, Hawkins J, Duddy G, Grau E, Pugh PL et al (2003) BACE1 transgenic and knockout mice: identification of neurochemical deficits and behavioral changes. Mol Cell Neurosci 24:646–655
Castro A, Martinez A (2006) Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors. Curr Pharm Des 12(33):4377–4387
Citron M (2004) Beta-secretase inhibition for the treatment of alzheimer disease-promise and challenge. Trends Pharmacol Sci 25:92–97
Gilgun-Sherki Y, Melamed E, Offen D (2001) Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40(8):959–975
Hashimoto M, Rockenstein E, Crews L, Masliah E (2003) Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer’s and Parkinson’s diseases. NeuroMol Med 4(1–2):21–36
Huang WY, Chao XJ, Ouyang Y, Liu A, He X, Chen M, Wang L, Liu J, Yu S, Rapposelli S, Pi R (2012) Tacrine-6-ferulic acid, a novel multifunctional dimer against Alzheimer’s disease, prevents oxidative stress-induced neuronal death through activating Nrf2/ARE/HO-1 pathway in HT22 cells. CNS Neurosci Ther 18:950–952
Ma ZC, Hong Q, Wang YG, Liang QD, Tan HL, Xiao CR, Tang XL, Shao S, Zhou SS, Gao Y (2011) Ferulic acid induces heme oxygenase-1 via activation of ERK and Nrf2. Drug Discov Ther 5:299–305
Ono K, Hasegawa K, Naiki H, Yamada M (2004) Curcumin has potent anti-amyloidogenic effects for Alzheimer’s beta-amyloid fibrils in vitro. J Neurosci Res 75:742–750
Sultana R, Butterfield DA (2010) Role of oxidative stress in progression of Alzheimer’s disease. J Alzheimer Dis 19(1):341–353
Cohen E, Bieschke J, Perciavalle RM, Kelly JW, Dillin A (2006) Opposing activities protect against age-onset proteotoxicity. Science 313(5793):1604–1610
Fukuda H, Komamine A (1982) Lignin synthesis and its related enzymes as markers of tracheary-element differentiation in single cells isolated from the mesophyll of Zinnia elegans. Planta 155(5):423–430
Acknowledgements
This work being supported from the funds recieved from the Department of Science and Technology, New Delhi, India (SR/CSI/288/2012/G), awarded to AKM Junior Research Fellowship (JRF) from University Grants Commission (CSIR-UGC JRF), New Delhi, India, to SK being thankfully acknowledged.
Conflict of Interest
Authors declare that no conflict of interest exists.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kaur, S., Dhiman, M., Mantha, A.K. (2018). Ferulic Acid: A Natural Antioxidant with Application Towards Neuroprotection Against Alzheimer’s Disease. In: Rani, V., Yadav, U. (eds) Functional Food and Human Health. Springer, Singapore. https://doi.org/10.1007/978-981-13-1123-9_25
Download citation
DOI: https://doi.org/10.1007/978-981-13-1123-9_25
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1122-2
Online ISBN: 978-981-13-1123-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)